This chapter explores the rationale, benefits and challenges of transcatheter aortic valve implantation (TAVI) for the treatment for native pure aortic regurgitation (NPAR). The epidemiology, natural history and current management of NPAR will be discussed. Evidence pertaining to TAVI for NPAR with non-dedicated devices, both early- and new-generation, and new-generation dedicated devices will be finally examined.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Future Challenges: Transcatheter Aortic Valve Implantation for Pure Aortic Regurgitation

  • Pier Pasquale Leone,
  • Abdullah Aftab,
  • Damiano Regazzoli,
  • Bernhard Reimers

摘要

This chapter explores the rationale, benefits and challenges of transcatheter aortic valve implantation (TAVI) for the treatment for native pure aortic regurgitation (NPAR). The epidemiology, natural history and current management of NPAR will be discussed. Evidence pertaining to TAVI for NPAR with non-dedicated devices, both early- and new-generation, and new-generation dedicated devices will be finally examined.